Evidence map›Paper›PMID 30842227›Full record

ArticleJournal of clinical microbiology2019

Development and Multicentric Validation of a Lateral Flow Immunoassay for Rapid Detection of MCR-1-Producing

Hervé Volland, Laurent Dortet, Sandrine Bernabeu, Hervé Boutal, Marisa Haenni, Jean-Yves Madec, Frédéric Robin, Racha Beyrouthy, Thierry Naas, Stéphanie Simon

Open access · hybridAbstract readMulticenter StudyValidation Study
In one paragraph

Article in Journal of clinical microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. The First Report ofMicroorganisms · 2024
    Article
  8. Review
  9. Article
  10. The Clash of the Titans: COVID-19, Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hervé VollandService de Pharmacologie et Immuno-analyse (SPI), JOLIOT, CEA, INRA, Université Paris-Saclay, Gif sur Yvette, France herve.volland@cea.fr.
Laurent DortetEA7361, UPSUD, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Hôpital de Bicêtre, APHP, Le Kremlin Bicêtre, France.
Sandrine BernabeuEA7361, UPSUD, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Hôpital de Bicêtre, APHP, Le Kremlin Bicêtre, France.
Hervé BoutalService de Pharmacologie et Immuno-analyse (SPI), JOLIOT, CEA, INRA, Université Paris-Saclay, Gif sur Yvette, France.
Marisa HaenniUnité Antibiorésistance et Virulence Bactériennes (AVB), Université de Lyon-Anses, Lyon, France.
Jean-Yves MadecUnité Antibiorésistance et Virulence Bactériennes (AVB), Université de Lyon-Anses, Lyon, France.
Frédéric RobinCHU Clermont-Ferrand, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France.
Racha BeyrouthyCHU Clermont-Ferrand, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France.
Thierry NaasEA7361, UPSUD, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Hôpital de Bicêtre, APHP, Le Kremlin Bicêtre, France.ORCID 0000-0001-9937-9572
Stéphanie SimonService de Pharmacologie et Immuno-analyse (SPI), JOLIOT, CEA, INRA, Université Paris-Saclay, Gif sur Yvette, France.
CNR de la Résistance aux Antibiotiques · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colistin has become a last-resort antibiotic for the treatment of infections caused by highly drug-resistant Gram-negative bacteria. Moreover, it has been widely used in the livestock sector. As a consequence, colistin resistance is emerging worldwide. Among the colistin resistance mechanisms, the spread of the plasmid-encoded colistin resistance gene

Indexed as

Capillary ActionImmunoassayAnimalsAnti-Bacterial AgentsBacterial ProteinsColistinDrug Resistance, BacterialEnterobacteriaceaeEnterobacteriaceae InfectionsEscherichia coli ProteinsHumansMicrobial Sensitivity TestsPlasmidsAnti-Bacterial AgentsBacterial ProteinsColistinEscherichia coli ProteinsMCR-1 protein, E colidetectionlateral flow immunoassayMCR-1

Identifiers

PMID30842227
PMCPMC6498016
OpenAlexW2920287800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.